Published in Neuropeptides on December 27, 2007
Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg (2012) 1.71
The role of peptide YY in appetite regulation and obesity. J Physiol (2008) 1.32
Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes (2011) 1.19
Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism (2014) 1.18
NPY receptors as potential targets for anti-obesity drug development. Br J Pharmacol (2011) 0.96
NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice. PLoS One (2010) 0.92
Obesity: considerations about etiology, metabolism, and the use of experimental models. Diabetes Metab Syndr Obes (2012) 0.90
The role of fatty acids in insulin resistance. Lipids Health Dis (2015) 0.88
The gut hormones in appetite regulation. J Obes (2011) 0.88
Central inflammation and leptin resistance are attenuated by ginsenoside Rb1 treatment in obese mice fed a high-fat diet. PLoS One (2014) 0.86
Specific appetite, energetic and metabolomics responses to fat overfeeding in resistant-to-bodyweight-gain constitutional thinness. Nutr Diabetes (2014) 0.81
Y1 and Y5 receptors are both required for the regulation of food intake and energy homeostasis in mice. PLoS One (2012) 0.79
The use of animal models to decipher physiological and neurobiological alterations of anorexia nervosa patients. Front Endocrinol (Lausanne) (2015) 0.77
Melanocortin neurons: multiple routes to regulation of metabolism. Biochim Biophys Acta (2017) 0.75
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science (2013) 6.29
Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J (2008) 4.28
Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med (2007) 3.36
Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab (2006) 2.23
Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med (2007) 2.20
Hypothalamic Y2 receptors regulate bone formation. J Clin Invest (2002) 2.01
Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab (2010) 1.71
NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides (2004) 1.63
Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology (2008) 1.53
Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models. PLoS One (2010) 1.44
Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev (2002) 1.38
Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci U S A (2002) 1.37
Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci (2003) 1.36
Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab (2013) 1.33
Deletion of β-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation. J Bone Miner Res (2012) 1.29
The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci (2010) 1.29
Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J Comp Neurol (2006) 1.28
Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus. J Neurochem (2005) 1.26
A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med (2005) 1.25
Maintenance of paternal methylation and repression of the imprinted H19 gene requires MBD3. PLoS Genet (2007) 1.24
Fat aussie--a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol Endocrinol (2006) 1.18
c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J Clin Invest (2004) 1.18
Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J Neurochem (2003) 1.18
Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction. Biochem Biophys Res Commun (2006) 1.15
Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem (2007) 1.14
Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem (2007) 1.14
Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors. Brain (2007) 1.13
TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator. PLoS One (2013) 1.12
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant (2011) 1.12
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS One (2012) 1.12
Behavioural profile of a new mouse model for NPY deficiency. Eur J Neurosci (2008) 1.10
The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. Eur J Neurosci (2005) 1.10
Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways. J Bone Miner Res (2005) 1.10
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL. J Biol Chem (2010) 1.10
Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res (2003) 1.09
The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer. Pharmacol Ther (2011) 1.09
Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS One (2009) 1.04
Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Mol Cell Biol (2003) 1.03
Nutrition-related peptides and bone homeostasis. J Bone Miner Res (2006) 1.03
Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res (2003) 1.03
Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15. J Cachexia Sarcopenia Muscle (2012) 1.02
Neuropeptide Y and peptide YY: important regulators of energy metabolism. Curr Opin Endocrinol Diabetes Obes (2011) 1.02
Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res (2006) 1.02
Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus. Neurobiol Dis (2006) 1.01
Behavioral profiling of NPY in aggression and neuropsychiatric diseases. Peptides (2006) 1.01
NPY regulation of bone remodelling. Neuropeptides (2009) 0.99
Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues. Br J Pharmacol (2003) 0.98
Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes (2002) 0.98
Neuropeptide Y in the recurrent mossy fiber pathway. Peptides (2007) 0.97
Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity. J Bone Miner Res (2010) 0.97
Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2α accumulation and promotes migration and invasion. PLoS One (2011) 0.97